Latest It Compliance News

Neurizon Therapeutics has secured trademark protection for its NEURIZON® brand across major pharmaceutical markets, reinforcing its intellectual property strategy as it advances its lead drug candidate NUZ-001.

FBR Limited has secured a binding conditional purchase order worth AUD 990,000 from a leading US heavy equipment dealer for its Mantis welding robot, marking a significant milestone during its prototyping phase.

American Uranium's recent hydrogeological pump tests at the Lo Herma project validate key aquifer properties consistent with nearby operating ISR uranium mines, supporting upcoming resource and scoping study updates.

Bellevue Gold Limited reported a robust cash flow and significant debt reduction in its December 2025 quarter, ending with a strong cash position of A$165.1 million. The company made early principal repayments on its project loan facility, lowering outstanding debt to A$100 million.

Richmond Vanadium Technology Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity and attributing the surge to broader market interest and improved liquidity.

The a2 Milk Company has responded to an ASX price query denying any undisclosed information behind recent share price moves, attributing the volatility to China’s latest birth statistics.

Phoslock Environmental Technologies has amended its December 2025 quarterly report to correct funding data and withdraw its sales outlook, while reporting improved cash flow and resuming factory operations.

Alice Queen Limited has addressed a recent doubling in its share price, attributing the surge to rising gold prices and ongoing project developments rather than undisclosed information.

DXN Limited has signed a strategic MOU with Super Sistem Indonesia to form a joint venture targeting Indonesia’s rapidly expanding digital infrastructure market, aiming for US$7 million in revenue over three years.

Mitchell Asset Management challenges Identitii Limited’s recent rights issue, alleging it could unfairly boost Beauvais Capital’s stake close to 50%, sparking a potential showdown at the Takeovers Panel.

Jupiter Energy reported steady oil production and US$1.6 million in domestic sales for Q4 2025, while completing integration of its West Zhetybai oilfield into a regional gas utilisation network.

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.